Controversy has led to small fall in sales of drug eluting stentsBMJ 2006; 333 doi: https://doi.org/10.1136/bmj.39027.561493.DB (Published 09 November 2006) Cite this as: BMJ 2006;333:985
- Geoff Watts
Fears about the safety of drug eluting stents have been reawakened this week with the publication of an article on the apparently thrombogenic effect of these devices.
The article in the New England Journal of Medicine (2006;355:1949-52) outlines the history of fears about the devices, explains how the US Food and Drug Administration and the manufacturers have so far responded to professionals' concerns, and details the most recent studies of the safety of stents. Written by Miriam Shuchman, an assistant professor at the School of Medicine and Biomedical Sciences at the University of Buffalo, it concludes that the damage to the “golden reputation” of drug eluting stents …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial